Skip to main content
. 2025 Nov 18;8:0883. doi: 10.34133/research.0883

Fig. 7.

Fig. 7.

(A) Schematic diagram of intravenous TPP@(CeO2+ROF) targeting mitochondria to release drugs, exerting protective effects against ischemic stroke. (B) Electron microscopy images of TPP@(CeO2+ROF) aggregation in mitochondria. (C) Mitosox Red fluorescent probe was used to assess mitochondrial ROS levels following treatment with each experimental group. (D) TPP@(CeO2+ROF) treatment modulated CD86 and CD206 expression in microglia [180]. Copyright 2024, American Chemical Society. (E) Schematic diagram demonstrating how RMVs modulate oxidative stress in activated macrophages to aid wound healing. (F) RMV normalizes mtROS levels in LPS-affected macrophages. (G) 3-HPA reverses the impact of LPS on mitochondrial permeability in macrophages. (H) RMV reverses the classical macrophage activation pathway promoted by LPS [182]. Copyright 2024, Wiley-VCH GmbH.